JUPITER NEUROSCIENCES, INC.

Jupiter Neurosciences is a clinical-stage biopharmaceutical company developing treatments for neuroinflammation and central nervous system disorders using its proprietary JOTROL™ platform, an enhanced oral formulation of resveratrol that achieves superior bioavailability compared to standard resveratrol. The company operates through two revenue-generating segments: a pharmaceutical division pursuing rare disease and neurological indications (such as Parkinson's disease and mild cognitive impairment) through licensing agreements with larger pharma companies, and a direct-to-consumer wellness brand offering premium longevity and cognitive health supplements. The company generates revenue through out-licensing pharmaceutical rights to larger pharma partners and through e-commerce sales of its consumer supplement products to health-conscious consumers seeking science-backed formulations.